This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parent, L. J.
Right arrow Articles by Craven, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parent, L. J.
Right arrow Articles by Craven, R. C.

 Previous Article  |  Next Article 

Journal of Virology, January 2000, p. 164-172, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

RNA Dimerization Defect in a Rous Sarcoma Virus Matrix Mutant

Leslie J. Parent,1,2 Tina M. Cairns,2 Jessica A. Albert,1 Carol B. Wilson,2 John W. Wills,2 and Rebecca C. Craven2,*

Departments of Medicine1 and Microbiology and Immunology,2 The Pennsylvania State University College of Medicine, M. S. Hershey Medical Center, Hershey, Pennsylvania 17033

Received 26 May 1999/Accepted 17 September 1999

The retrovirus matrix (MA) sequence of the Gag polyprotein has been shown to contain functions required for membrane targeting and binding during particle assembly and budding. Additional functions for MA have been proposed based on the existence of MA mutants in Rous sarcoma virus (RSV), murine leukemia virus, human immunodeficiency virus type 1, and human T-cell leukemia virus type 1 that lack infectivity even though they release particles of normal composition. Here we describe an RSV MA mutant with a surprising and previously unreported phenotype. In the mutant known as Myr1E, the small membrane-binding domain of the Src oncoprotein has been added as an N-terminal extension of Gag. While Myr1E is not infectious, full infectivity can be reestablished by a single amino acid substitution in the Src sequence (G2E), which eliminates the addition of myristic acid and the membrane-binding capacity of this foreign sequence. The presence of myristic acid at the N terminus of the Myr1E Gag protein does not explain its replication defect, because other myristylated derivatives of RSV Gag are fully infectious (e.g., Myr2 [C. R. Erdie and J. W. Wills, J. Virol. 64:5204-5208, 1990]). Biochemical analyses of Myr1E particles reveal that they contain wild-type levels of the Gag cleavage products, Env glycoproteins, and reverse transcriptase activity when measured on an exogenous template. Genomic RNA incorporation appears to be mildly reduced compared to the wild-type level. Unexpectedly, RNA isolated from Myr1E particles is monomeric when analyzed on nondenaturing Northern blots. Importantly, the insertional mutation does not lie within previously identified dimer linkage sites. In spite of the dimerization defect, the genomic RNA from Myr1E particles serves efficiently as a template for reverse transcription as measured by an endogenous reverse transcriptase assay. In marked contrast, after infection of avian cells, the products of reverse transcription are nearly undetectable. These findings might be explained either by the loss of a normal function of MA needed in the formation or stabilization of RNA dimers or by the interference in such events by the mutant MA molecules. It is possible that Myr1E viruses package a single copy of viral RNA.

* Corresponding author. Mailing address: Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, 500 University Dr., P.O. Box 850, Hershey, PA 17033. Phone: (717) 531-3528. Fax: (717) 531-6522. E-mail: rcraven{at}psu.edu.

Journal of Virology, January 2000, p. 164-172, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Garbitt-Hirst, R., Kenney, S. P., Parent, L. J. (2009). Genetic Evidence for a Connection between Rous Sarcoma Virus Gag Nuclear Trafficking and Genomic RNA Packaging. J. Virol. 83: 6790-6797 [Abstract] [Full Text]  
  • Kenney, S. P., Lochmann, T. L., Schmid, C. L., Parent, L. J. (2008). Intermolecular Interactions between Retroviral Gag Proteins in the Nucleus. J. Virol. 82: 683-691 [Abstract] [Full Text]  
  • Scheifele, L. Z., Kenney, S. P., Cairns, T. M., Craven, R. C., Parent, L. J. (2007). Overlapping Roles of the Rous Sarcoma Virus Gag p10 Domain in Nuclear Export and Virion Core Morphology. J. Virol. 81: 10718-10728 [Abstract] [Full Text]  
  • Spidel, J. L., Wilson, C. B., Craven, R. C., Wills, J. W. (2007). Genetic Studies of the {beta}-Hairpin Loop of Rous Sarcoma Virus Capsid Protein. J. Virol. 81: 1288-1296 [Abstract] [Full Text]  
  • Fu, W., Dang, Q., Nagashima, K., Freed, E. O., Pathak, V. K., Hu, W.-S. (2006). Effects of Gag Mutation and Processing on Retroviral Dimeric RNA Maturation. J. Virol. 80: 1242-1249 [Abstract] [Full Text]  
  • Scheifele, L. Z., Ryan, E. P., Parent, L. J. (2005). Detailed Mapping of the Nuclear Export Signal in the Rous Sarcoma Virus Gag Protein. J. Virol. 79: 8732-8741 [Abstract] [Full Text]  
  • Garbitt, R. A., Bone, K. R., Parent, L. J. (2004). Insertion of a Classical Nuclear Import Signal into the Matrix Domain of the Rous Sarcoma Virus Gag Protein Interferes with Virus Replication. J. Virol. 78: 13534-13542 [Abstract] [Full Text]  
  • Callahan, E. M., Wills, J. W. (2003). Link between Genome Packaging and Rate of Budding for Rous Sarcoma Virus. J. Virol. 77: 9388-9398 [Abstract] [Full Text]  
  • Scheifele, L. Z., Rhoads, J. D., Parent, L. J. (2002). Specificity of Plasma Membrane Targeting by the Rous Sarcoma Virus Gag Protein. J. Virol. 77: 470-480 [Abstract] [Full Text]  
  • Scheifele, L. Z., Garbitt, R. A., Rhoads, J. D., Parent, L. J. (2002). Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein. Proc. Natl. Acad. Sci. USA 99: 3944-3949 [Abstract] [Full Text]  
  • Sakuragi, J.-i., Iwamoto, A., Shioda, T. (2002). Dissociation of Genome Dimerization from Packaging Functions and Virion Maturation of Human Immunodeficiency Virus Type 1. J. Virol. 76: 959-967 [Abstract] [Full Text]  
  • Sakuragi, J.-I., Shioda, T., Panganiban, A. T. (2001). Duplication of the Primary Encapsidation and Dimer Linkage Region of Human Immunodeficiency Virus Type 1 RNA Results in the Appearance of Monomeric RNA in Virions. J. Virol. 75: 2557-2565 [Abstract] [Full Text]  
  • Shehu-Xhilaga, M., Crowe, S. M., Mak, J. (2001). Maintenance of the Gag/Gag-Pol Ratio Is Important for Human Immunodeficiency Virus Type 1 RNA Dimerization and Viral Infectivity. J. Virol. 75: 1834-1841 [Abstract] [Full Text]  
  • Cairns, T. M., Craven, R. C. (2001). Viral DNA Synthesis Defects in Assembly-Competent Rous Sarcoma Virus CA Mutants. J. Virol. 75: 242-250 [Abstract] [Full Text]  
  • Garbitt, R. A., Albert, J. A., Kessler, M. D., Parent, L. J. (2001). trans-Acting Inhibition of Genomic RNA Dimerization by Rous Sarcoma Virus Matrix Mutants. J. Virol. 75: 260-268 [Abstract] [Full Text]  
  • Jewell, N. A., Mansky, L. M. (2000). In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly. J. Gen. Virol. 81: 1889-1899 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»